For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) was $9.34 for the day, down -5.27% from the previous closing price of $9.86. In other words, the price has decreased by -$5.27 from its previous closing price. On the day, 1.26 million shares were traded. AVAH stock price reached its highest trading level at $9.92 during the session, while it also had its lowest trading level at $9.34.
Ratios:
Our analysis of AVAH’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 19.37 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 25.94. For the most recent quarter (mrq), Quick Ratio is recorded 1.09 and its Current Ratio is at 1.09.
On August 19, 2025, UBS Upgraded its rating to Neutral which previously was Sell but kept the price unchanged to $8.
Barclays Upgraded its Equal Weight to Overweight on August 19, 2025, while the target price for the stock was maintained at $9.50.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 24 ’25 when VIGANO PAUL R sold 1,500,000 shares for $9.00 per share. The transaction valued at 13,500,000 led to the insider holds 362,746 shares of the business.
J.H. Whitney Equity Partners V sold 1,251,909 shares of AVAH for $11,267,181 on Oct 24 ’25. The 10% Owner now owns 19,292,787 shares after completing the transaction at $9.00 per share. On Oct 24 ’25, another insider, WILLIAMS ROBERT M JR, who serves as the 10% Owner of the company, sold 1,500,000 shares for $9.00 each. As a result, the insider received 13,500,000 and left with 362,746 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVAH now has a Market Capitalization of 1951232256 and an Enterprise Value of 3341602048. As of this moment, Aveanna’s Price-to-Earnings (P/E) ratio for their current fiscal year is 124.20, and their Forward P/E ratio for the next fiscal year is 17.54. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.07. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.90. Its current Enterprise Value per Revenue stands at 1.534 whereas that against EBITDA is 14.393.
Stock Price History:
The Beta on a monthly basis for AVAH is 2.06, which has changed by 1.0348585 over the last 52 weeks, in comparison to a change of 0.19088471 over the same period for the S&P500. Over the past 52 weeks, AVAH has reached a high of $10.32, while it has fallen to a 52-week low of $3.67. The 50-Day Moving Average of the stock is 7.64%, while the 200-Day Moving Average is calculated to be 59.47%.
Shares Statistics:
AVAH traded an average of 1.64M shares per day over the past three months and 2122700 shares per day over the past ten days. A total of 208.26M shares are outstanding, with a floating share count of 54.20M. Insiders hold about 74.06% of the company’s shares, while institutions hold 23.49% stake in the company. Shares short for AVAH as of 1760486400 were 5152755 with a Short Ratio of 3.14, compared to 1757894400 on 5083804. Therefore, it implies a Short% of Shares Outstanding of 5152755 and a Short% of Float of 7.5200000000000005.
Earnings Estimates
. The current assessment of Aveanna Healthcare Holdings Inc (AVAH) involves the perspectives of 3.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $0.1, with high estimates of $0.12 and low estimates of $0.08.
Analysts are recommending an EPS of between $0.59 and $0.45 for the fiscal current year, implying an average EPS of $0.53. EPS for the following year is $0.53, with 9.0 analysts recommending between $0.62 and $0.37.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 7 analysts. It ranges from a high estimate of $619.88M to a low estimate of $575M. As of. The current estimate, Aveanna Healthcare Holdings Inc’s year-ago sales were $509.02MFor the next quarter, 7 analysts are estimating revenue of $591.98M. There is a high estimate of $617.8M for the next quarter, whereas the lowest estimate is $578.5M.
A total of 8 analysts have provided revenue estimates for AVAH’s current fiscal year. The highest revenue estimate was $2.39B, while the lowest revenue estimate was $2.3B, resulting in an average revenue estimate of $2.33B. In the same quarter a year ago, actual revenue was $2.02BBased on 8 analysts’ estimates, the company’s revenue will be $2.49B in the next fiscal year. The high estimate is $2.58B and the low estimate is $2.42B.
